Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-28

Clinical Trial Update: Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of risedronate in children with osteogenesis imperfecta; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • risedronate (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Osteogenesis Imperfecta | Phase 3 | Status: COMPLETED | Results posted: 2010-06-28